These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 553136)

  • 1. An unbalanced experimental design for dose response studies.
    Farmer JH; Uhler RJ; Haley TJ
    J Environ Pathol Toxicol; 1977; 1(2):293-9. PubMed ID: 553136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of "safe doses" in carcinogenic experiments.
    Hartley HO; Sielken RL
    Biometrics; 1977 Mar; 33(1):1-30. PubMed ID: 843567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the standard deviation in the estimation of benchmark doses with continuous data.
    Gaylor DW; Slikker W
    Risk Anal; 2004 Dec; 24(6):1683-7. PubMed ID: 15660621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved procedure for low-dose carcinogenic risk assessment from animal data.
    Crump KS
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):339-48. PubMed ID: 6520736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A statistical test of compatibility of data sets to a common dose-response model.
    Stiteler WM; Knauf LA; Hertzberg RC; Schoeny RS
    Regul Toxicol Pharmacol; 1993 Dec; 18(3):392-402. PubMed ID: 8128001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
    Zhu Y; Wang T; Jelsovsky JZ
    Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
    Kuljus K; von Rosen D; Sand S; Victorin K
    Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient design for estimation of median lethal dose and quantal dose-response curves.
    Kalish LA
    Biometrics; 1990 Sep; 46(3):737-48. PubMed ID: 2242412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methods of risk assessment from data of experimental carcinogenesis studies].
    Roller M; Csicsaky M; Pott F
    Zentralbl Hyg Umweltmed; 1992 Mar; 192(6):479-93. PubMed ID: 1315551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designs for phase I clinical trials with multiple courses of subjects at different doses.
    Fan SK; Wang YG
    Biometrics; 2007 Sep; 63(3):856-64. PubMed ID: 17403103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Methyl Carbamate (CAS No. 598-55-0) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 328():1-176. PubMed ID: 12732908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model uncertainty and risk estimation for experimental studies of quantal responses.
    Bailer AJ; Noble RB; Wheeler MW
    Risk Anal; 2005 Apr; 25(2):291-9. PubMed ID: 15876205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The weight of the evidence among group C carcinogens.
    Engler R; Rinde E; Frick C; Quest J
    Qual Assur; 1991 Oct; 1(1):51-69. PubMed ID: 1669970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety evaluation of neem (Azadirachta indica) derived pesticides.
    Boeke SJ; Boersma MG; Alink GM; van Loon JJ; van Huis A; Dicke M; Rietjens IM
    J Ethnopharmacol; 2004 Sep; 94(1):25-41. PubMed ID: 15261960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of number of doses for maximum likelihood estimation of the ED50 for quantal dose-response data.
    Müller HG; Schmitt T
    Biometrics; 1990 Mar; 46(1):117-29. PubMed ID: 2350566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
    Farmer JH; Kodell RL; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):55-68. PubMed ID: 7365386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.